You searched for Antibody candidate - Page 27 of 69

News and Trends 24 Feb 2020

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

German biotech Adrenomed reports that its first-in-class antibody drug adrecizumab was well-tolerated by septic shock patients and met its primary goal in a phase II trial. The company says it…

February 24, 2020 - 3 minutesmins - By Helen Albert

In Depth 13 Jun 2023

Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines

…treatment of Alzheimer’s disease In September 2022, the monoclonal antibody lecanemab, which targets a toxic species of Abeta protein, slowed cognitive decline in early Alzheimer’s disease by approximately 30% in…

June 13, 2023 - 7 minutesmins - By External Contributor

News and Trends 7 Jan 2020

Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug

…treatment based on antibody-drug conjugate technology from the Dutch company Synaffix. Synaffix develops technology to produce antibody-drug conjugates, commonly known as ADCs, which are antibodies with toxic chemotherapy drugs attached….

January 7, 2020 - 2 minutesmins - By Jonathan Smith

Interview 25 Oct 2018

Mastering the Competitive World of Immuno-oncology

…of the antibody field and started his first company, 4-Antibody, in 2004. Before a successful sale to Agenus in 2014, the company developed therapeutic antibodies for a range of different…

October 25, 2018 - 5 minutesmins - By Helen Albert

News and Trends 15 Dec 2022

Solve Therapeutics launches to tackle cancer

…reviewing other potential in-licensing opportunities as well as performing in-house antibody discovery research. The company’s focus is on the development of novel mAbs, antibody drug conjugates incorporating next-generation linker and…

December 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Sep 2017

A Swedish-Spanish Team Takes on a New Immuno-Oncology Target

…cells and can promote the survival, expansion and activity of these immune cells specialized in fighting cancer. Alligator Bioscience already has two antibody candidates in its pipeline that target…

September 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jul 2022

Trial for drug targeting cancerous tumors begins in China

…(July 15). It is the thirteenth innovative oncology drug candidate discovered in-house by HUTCHMED and it is the company’s second large molecule drug candidate to enter clinical studies. The investigational…

July 18, 2022 - 3 minutesmins - By Liza Laws

ASCO 2024: advances in oncology clinical trials

In Depth 10 Jun 2024

ASCO 2024: The latest advances in oncology clinical trials

…care from chemotherapy to novel targeted therapies. At ASCO 2024, AbbVie’s antibody drug conjugate (ADC) platform was revealed, as the drugs are being developed to target solid tumors. A few…

June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 9 Apr 2024

Eight biotech companies you should know about in Austria

…most advanced is the chronic inflammation candidate ON104, which is a monoclonal antibody that helps override the immunosuppressive effects of glucocorticoids and neutralize the effects of oxMIF. ON104 is in…

April 9, 2024 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 20 Jul 2023

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

…further highlight the therapeutic significance of its proprietary anti-GDF-15 antibody candidate, visugromab, currently in advanced phase 2 clinical studies. The foundational research, which was performed with founder Jörg Wischhusen and…

July 20, 2023 - 3 minutesmins - By Jim Cornall

osteoporosis vertebral column denosumab amgen ucb

News and Trends 22 Feb 2016

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a phase III Osteoporosis trial, FRAME in partnership with Amgen. The drug showed 75% improvement…

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

tumor cancer immunotherapy alderaan biotech

News and Trends 9 Jan 2020

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

…lead cancer immunotherapy into phase I testing. The candidate is an antibody that depletes T regulatory cells, or Tregs, which help tumors to evade the immune system. Alderaan expects to…

January 9, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines

Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug

Mastering the Competitive World of Immuno-oncology

Solve Therapeutics launches to tackle cancer

A Swedish-Spanish Team Takes on a New Immuno-Oncology Target

Trial for drug targeting cancerous tumors begins in China

ASCO 2024: The latest advances in oncology clinical trials

Eight biotech companies you should know about in Austria

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!